Civitas Resources: Strategic Asset Sale and Valuation Opportunity Justify Buy Rating
Mizuho Securities analyst William Janela has maintained their bullish stance on CIVI stock, giving a Buy rating on January 13.Stay Ahead of ...
Strategic Positioning and Growth Prospects Justify Buy Rating for Expand Energy
Expand Energy (EXE) has received a new Buy rating, initiated by J.P. Morgan analyst, Zach Parham.Stay Ahead of the Market:Discover ...
Kratos: Solid Market Trends, New Contracts And High Institution Ownership Justify Buying
Kratos' new contracts highlight its technological advancements and long-term growth potential. Learn why I remain bullish on ...
MarketWatch19d
Mondelez is reportedly exploring a Hershey acquisition. Drugs like Ozempic could justify a deal.
Drugs like Ozempic could justify a deal. Hershey ‘now faces long-term headwinds from the expansion of GLP-1 drugs and heightened scrutiny on unhealthy food in the U.S.,’ TD Cowen says ...
$48 Billion Bond Investor Sees East Europe Too Risky to Wade In
Brandywine, which manages $48 billion in fixed-income assets, prefers to remain on the sidelines in the European Union’s east ...